How Specialty Pharmacy Can Support Value-Based Care and Population Health
How Specialty Pharmacy Can Address and Impact Social Determinants of Health
Advancements in Rare Disease Treatment and Management
This white paper discusses how health system-owned specialty pharmacies leveraging Shields’ integrated care model, data aggregation and acceleration solutions can overcome challenges and barriers to care for specialty patients with…
Redefining the Role of Health Systems as a Specialty Pharmacy Solution for Drug Manufacturers
This white paper discusses how a specialty pharmacy acceleration company allows drug manufacturers to access the expertise of health systems and their specialty pharmacies through a single point of contact.…
Addressing Total Cost of Care Across the Specialty Population
This white paper describes the impact of health system specialty pharmacy utilizing an integrated care model on clinical outcomes and total cost of care.
How Specialty Pharmacy Can Drive Better Outcomes in Diabetes
This white paper explores the benefits of applying a high-touch specialty pharmacy care model, such as the Shields Diabetes Care Program, in reducing HbA1c levels and providing other clinical and…
How Specialty Pharmacy Can Drive Better Outcomes in Cystic Fibrosis
This white paper explores how a high-touch integrated specialty pharmacy care model can help patients with cystic fibrosis manage the complexity of their treatment regimen and achieve their therapy goals.…
How Specialty Pharmacy Can Drive Better Outcomes in Multiple Sclerosis
This white paper explores how a high-touch IDN (Integrated Delivery Network) specialty pharmacy model can help MS patients overcome barriers to medication access and achievement of therapy goals, including limited…
More Health Systems, More Data, More Access: Bridging Divides Among Specialty Pharmacy Stakeholders for the Benefit of Complex Patients
- 1
- 2